Marshall Fordyce
Founder and CEO of Vera Therapeutics, leading development of atacicept for IgA nephropathy and overseeing the company's phase 3 results and BLA filing with the FDA.
Best podcasts with Marshall Fordyce
Ranked by the Snipd community
Jan 12, 2026 • 11min
SF Healthcare Week: Vera Therapeutics’ announced this week that the FDA accepted the company’s filing for atacicept, a potential new treatment for IgA Nephropathy
Marshall Fordyce, Founder and CEO of Vera Therapeutics, dives into the groundbreaking potential of atacicept for treating IgA nephropathy. He discusses the impressive FDA acceptance of their BLA filing and the important role of Phase III data published in NEJM. Fordyce explains how atacicept uniquely targets BAFF and APRIL to reduce immune complexes and improve treatment outcomes. As they prepare for a commercial launch, he highlights patient-friendly dosing options and clear communication with the FDA.
Aug 1, 2024 • 33min
Autoimmune Innovations: Insights from Marshall Fordyce, Founder & CEO, Vera Therapeutics on Biotech
Marshall Fordyce, Founder and CEO of Vera Therapeutics, shares his journey from medicine to biotech innovation. He discusses the strategic pivot towards treating autoimmune diseases, particularly Ig nephropathy with atacicept, a B-cell modulator. The conversation covers the importance of scientific rigor and adaptability in the biotech industry, while exploring the mechanisms behind new therapeutic strategies for conditions like systemic lupus. Fordyce emphasizes the balance of accountability and mentorship in navigating the evolving landscape of biotech.
